BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Kros JM, Mustafa DM, Dekker LJ, Sillevis Smitt PA, Luider TM, Zheng PP. Circulating glioma biomarkers. Neuro Oncol 2015;17:343-60. [PMID: 25253418 DOI: 10.1093/neuonc/nou207] [Cited by in Crossref: 25] [Cited by in F6Publishing: 46] [Article Influence: 3.1] [Reference Citation Analysis]
Number Citing Articles
1 Cai J, Zeng C, Hua W, Qi Z, Song Y, Lu X, Li D, Zhang Z, Cui X, Zhang X, Yang Z, Zhang J, Quan K, Zhu W, Cai J, He C, Cheng SY, Zhang W, Mao Y. An integrative analysis of genome-wide 5-hydroxymethylcytosines in circulating cell-free DNA detects noninvasive diagnostic markers for gliomas. Neurooncol Adv 2021;3:vdab049. [PMID: 34151267 DOI: 10.1093/noajnl/vdab049] [Reference Citation Analysis]
2 Estival A, Sanz C, Ramirez JL, Velarde JM, Domenech M, Carrato C, de Las Peñas R, Gil-Gil M, Sepúlveda J, Armengol R, Cardiel I, Berrocal A, Luque R, Herrero A, Balana C. Pyrosequencing versus methylation-specific PCR for assessment of MGMT methylation in tumor and blood samples of glioblastoma patients. Sci Rep 2019;9:11125. [PMID: 31366977 DOI: 10.1038/s41598-019-47642-2] [Cited by in Crossref: 9] [Cited by in F6Publishing: 7] [Article Influence: 3.0] [Reference Citation Analysis]
3 Lin CY, Yang ST, Shen SC, Hsieh YC, Hsu FT, Chen CY, Chiang YH, Chuang JY, Chen KY, Hsu TI, Leong WC, Su YK, Lo WL, Yeh YS, Patria YN, Shih HM, Chang CC, Chou SY. Serum amyloid A1 in combination with integrin αVβ3 increases glioblastoma cells mobility and progression. Mol Oncol 2018;12:756-71. [PMID: 29603594 DOI: 10.1002/1878-0261.12196] [Cited by in Crossref: 13] [Cited by in F6Publishing: 13] [Article Influence: 3.3] [Reference Citation Analysis]
4 Huang Q, Chen H, Zuo B, Cheng C, Yu W, Yang Y. lncRNA NEF inhibits glioma by downregulating TGF-β1. Exp Ther Med 2019;18:692-8. [PMID: 31258706 DOI: 10.3892/etm.2019.7602] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
5 Sol N, In 't Veld SGJG, Vancura A, Tjerkstra M, Leurs C, Rustenburg F, Schellen P, Verschueren H, Post E, Zwaan K, Ramaker J, Wedekind LE, Tannous J, Ylstra B, Killestein J, Mateen F, Idema S, de Witt Hamer PC, Navis AC, Leenders WPJ, Hoeben A, Moraal B, Noske DP, Vandertop WP, Nilsson RJA, Tannous BA, Wesseling P, Reijneveld JC, Best MG, Wurdinger T. Tumor-Educated Platelet RNA for the Detection and (Pseudo)progression Monitoring of Glioblastoma. Cell Rep Med 2020;1:100101. [PMID: 33103128 DOI: 10.1016/j.xcrm.2020.100101] [Cited by in Crossref: 11] [Cited by in F6Publishing: 12] [Article Influence: 5.5] [Reference Citation Analysis]
6 Miyauchi E, Furuta T, Ohtsuki S, Tachikawa M, Uchida Y, Sabit H, Obuchi W, Baba T, Watanabe M, Terasaki T, Nakada M. Identification of blood biomarkers in glioblastoma by SWATH mass spectrometry and quantitative targeted absolute proteomics. PLoS One 2018;13:e0193799. [PMID: 29513714 DOI: 10.1371/journal.pone.0193799] [Cited by in Crossref: 35] [Cited by in F6Publishing: 28] [Article Influence: 8.8] [Reference Citation Analysis]
7 Guan Q, Yuan L, Lin A, Lin H, Huang X, Ruan J, Zhuo Z. KRAS gene polymorphisms are associated with the risk of glioma: a two-center case-control study. Transl Pediatr 2021;10:579-86. [PMID: 33850816 DOI: 10.21037/tp-20-359] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
8 He X, Qi Y, Zhang X, Liu X, Li X, Li S, Wu Y, Zhang Q. Current landscape of tumor-derived exosomal ncRNAs in glioma progression, detection, and drug resistance. Cell Death Dis 2021;12:1145. [PMID: 34887381 DOI: 10.1038/s41419-021-04430-z] [Reference Citation Analysis]
9 Ji X, Zhang H, Cui Q. A Panel of Synapse-Related Genes as a Biomarker for Gliomas. Front Neurosci 2020;14:822. [PMID: 32848578 DOI: 10.3389/fnins.2020.00822] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
10 Ly KI, Vakulenko-Lagun B, Emblem KE, Ou Y, Da X, Betensky RA, Kalpathy-Cramer J, Duda DG, Jain RK, Chi AS, Plotkin SR, Batchelor TT, Sorensen G, Rosen BR, Gerstner ER. Probing tumor microenvironment in patients with newly diagnosed glioblastoma during chemoradiation and adjuvant temozolomide with functional MRI. Sci Rep 2018;8:17062. [PMID: 30459364 DOI: 10.1038/s41598-018-34820-x] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.3] [Reference Citation Analysis]
11 Wang Q, Han B, Huang W, Qi C, Liu F. Identification of KIF15 as a potential therapeutic target and prognostic factor for glioma. Oncol Rep 2020;43:1035-44. [PMID: 32323839 DOI: 10.3892/or.2020.7510] [Reference Citation Analysis]
12 Rynkeviciene R, Simiene J, Strainiene E, Stankevicius V, Usinskiene J, Miseikyte Kaubriene E, Meskinyte I, Cicenas J, Suziedelis K. Non-Coding RNAs in Glioma. Cancers (Basel). 2018;11:pii: E17. [PMID: 30583549 DOI: 10.3390/cancers11010017] [Cited by in Crossref: 50] [Cited by in F6Publishing: 50] [Article Influence: 12.5] [Reference Citation Analysis]
13 Ellis HP, Greenslade M, Powell B, Spiteri I, Sottoriva A, Kurian KM. Current Challenges in Glioblastoma: Intratumour Heterogeneity, Residual Disease, and Models to Predict Disease Recurrence. Front Oncol 2015;5:251. [PMID: 26636033 DOI: 10.3389/fonc.2015.00251] [Cited by in Crossref: 56] [Cited by in F6Publishing: 59] [Article Influence: 8.0] [Reference Citation Analysis]
14 Bălașa A, Șerban G, Chinezu R, Hurghiș C, Tămaș F, Manu D. The Involvement of Exosomes in Glioblastoma Development, Diagnosis, Prognosis, and Treatment. Brain Sci 2020;10:E553. [PMID: 32823792 DOI: 10.3390/brainsci10080553] [Cited by in Crossref: 10] [Cited by in F6Publishing: 11] [Article Influence: 5.0] [Reference Citation Analysis]
15 Koga T, Li B, Figueroa JM, Ren B, Chen CC, Carter BS, Furnari FB. Mapping of genomic EGFRvIII deletions in glioblastoma: insight into rearrangement mechanisms and biomarker development. Neuro Oncol 2018;20:1310-20. [PMID: 29660021 DOI: 10.1093/neuonc/noy058] [Cited by in Crossref: 13] [Cited by in F6Publishing: 14] [Article Influence: 4.3] [Reference Citation Analysis]
16 Müller Bark J, Kulasinghe A, Chua B, Day BW, Punyadeera C. Circulating biomarkers in patients with glioblastoma. Br J Cancer 2020;122:295-305. [PMID: 31666668 DOI: 10.1038/s41416-019-0603-6] [Cited by in Crossref: 45] [Cited by in F6Publishing: 41] [Article Influence: 15.0] [Reference Citation Analysis]
17 Mouliere F, Smith CG, Heider K, Su J, van der Pol Y, Thompson M, Morris J, Wan JCM, Chandrananda D, Hadfield J, Grzelak M, Hudecova I, Couturier DL, Cooper W, Zhao H, Gale D, Eldridge M, Watts C, Brindle K, Rosenfeld N, Mair R. Fragmentation patterns and personalized sequencing of cell-free DNA in urine and plasma of glioma patients. EMBO Mol Med 2021;13:e12881. [PMID: 34291583 DOI: 10.15252/emmm.202012881] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
18 Koper-Lenkiewicz OM, Milewska AJ, Kamińska J, Sawicki K, Chrzanowski R, Zińczuk J, Reszeć J, Tylicka M, Matuszczak E, Matowicka-Karna J, Mariak Z, Mucha MW, Pawlak R, Dymicka-Piekarska V. Myelin-associated proteins are potential diagnostic markers in patients with primary brain tumour. Ann Med 2021;53:1710-21. [PMID: 34601991 DOI: 10.1080/07853890.2021.1983205] [Reference Citation Analysis]
19 Li L, Mu W, Wang Y, Liu Z, Liu Z, Wang Y, Ma W, Kong Z, Wang S, Zhou X, Wei W, Cheng X, Lin Y, Tian J. A Non-invasive Radiomic Method Using 18F-FDG PET Predicts Isocitrate Dehydrogenase Genotype and Prognosis in Patients With Glioma. Front Oncol 2019;9:1183. [PMID: 31803608 DOI: 10.3389/fonc.2019.01183] [Cited by in Crossref: 17] [Cited by in F6Publishing: 14] [Article Influence: 5.7] [Reference Citation Analysis]
20 Chen M, Zheng SH, Yang M, Chen ZH, Li ST. The diagnostic value of preoperative inflammatory markers in craniopharyngioma: a multicenter cohort study. J Neurooncol 2018;138:113-22. [PMID: 29388032 DOI: 10.1007/s11060-018-2776-x] [Cited by in Crossref: 13] [Cited by in F6Publishing: 10] [Article Influence: 3.3] [Reference Citation Analysis]
21 Hanemann CO, Blakeley JO, Nunes FP, Robertson K, Stemmer-Rachamimov A, Mautner V, Kurtz A, Ferguson M, Widemann BC, Evans DG, Ferner R, Carroll SL, Korf B, Wolkenstein P, Knight P, Plotkin SR; REiNS International Collaboration. Current status and recommendations for biomarkers and biobanking in neurofibromatosis. Neurology 2016;87:S40-8. [PMID: 27527649 DOI: 10.1212/WNL.0000000000002932] [Cited by in Crossref: 12] [Cited by in F6Publishing: 4] [Article Influence: 2.4] [Reference Citation Analysis]
22 Ivanov YD, Malsagova KA, Popov VP, Kupriyanov IN, Pleshakova TO, Galiullin RA, Ziborov VS, Dolgoborodov AY, Petrov OF, Miakonkikh AV, Rudenko KV, Glukhov AV, Smirnov AY, Usachev DY, Gadzhieva OA, Bashiryan BA, Shimansky VN, Enikeev DV, Potoldykova NV, Archakov AI. Micro-Raman Characterization of Structural Features of High-k Stack Layer of SOI Nanowire Chip, Designed to Detect Circular RNA Associated with the Development of Glioma. Molecules 2021;26:3715. [PMID: 34207029 DOI: 10.3390/molecules26123715] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
23 Zhang H, Yuan F, Qi Y, Liu B, Chen Q. Circulating Tumor Cells for Glioma. Front Oncol 2021;11:607150. [PMID: 33777749 DOI: 10.3389/fonc.2021.607150] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
24 Westphal M, Lamszus K. Circulating biomarkers for gliomas. Nat Rev Neurol 2015;11:556-66. [PMID: 26369507 DOI: 10.1038/nrneurol.2015.171] [Cited by in Crossref: 93] [Cited by in F6Publishing: 85] [Article Influence: 13.3] [Reference Citation Analysis]
25 Muskens IS, Zhou M, Mccoy L, Bracci PM, Hansen HM, Gauderman WJ, Wiencke JK, Wrensch MR, Wiemels JL. Immune factors preceding diagnosis of glioma: a Prostate Lung Colorectal Ovarian Cancer Screening Trial nested case-control study. Neurooncol Adv 2019;1:vdz031. [PMID: 31807733 DOI: 10.1093/noajnl/vdz031] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
26 Li W, Jia H, Li Q, Cui J, Li R, Zou Z, Hong X. Glycerophosphatidylcholine PC(36:1) absence and 3'-phosphoadenylate (pAp) accumulation are hallmarks of the human glioma metabolome. Sci Rep 2018;8:14783. [PMID: 30283018 DOI: 10.1038/s41598-018-32847-8] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 1.5] [Reference Citation Analysis]
27 Wang Y, Springer S, Zhang M, McMahon KW, Kinde I, Dobbyn L, Ptak J, Brem H, Chaichana K, Gallia GL, Gokaslan ZL, Groves ML, Jallo GI, Lim M, Olivi A, Quinones-Hinojosa A, Rigamonti D, Riggins GJ, Sciubba DM, Weingart JD, Wolinsky JP, Ye X, Oba-Shinjo SM, Marie SK, Holdhoff M, Agrawal N, Diaz LA Jr, Papadopoulos N, Kinzler KW, Vogelstein B, Bettegowda C. Detection of tumor-derived DNA in cerebrospinal fluid of patients with primary tumors of the brain and spinal cord. Proc Natl Acad Sci U S A 2015;112:9704-9. [PMID: 26195750 DOI: 10.1073/pnas.1511694112] [Cited by in Crossref: 186] [Cited by in F6Publishing: 175] [Article Influence: 26.6] [Reference Citation Analysis]
28 Tzaridis T, Reiners KS, Weller J, Bachurski D, Schäfer N, Schaub C, Hallek M, Scheffler B, Glas M, Herrlinger U, Wild S, Coch C, Hartmann G. Analysis of Serum miRNA in Glioblastoma Patients: CD44-Based Enrichment of Extracellular Vesicles Enhances Specificity for the Prognostic Signature. Int J Mol Sci 2020;21:E7211. [PMID: 33003586 DOI: 10.3390/ijms21197211] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 3.0] [Reference Citation Analysis]
29 Adamczyk LA, Williams H, Frankow A, Ellis HP, Haynes HR, Perks C, Holly JM, Kurian KM. Current Understanding of Circulating Tumor Cells - Potential Value in Malignancies of the Central Nervous System. Front Neurol 2015;6:174. [PMID: 26322014 DOI: 10.3389/fneur.2015.00174] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 1.6] [Reference Citation Analysis]
30 Best MG, Sol N, Zijl S, Reijneveld JC, Wesseling P, Wurdinger T. Liquid biopsies in patients with diffuse glioma. Acta Neuropathol 2015;129:849-65. [PMID: 25720744 DOI: 10.1007/s00401-015-1399-y] [Cited by in Crossref: 53] [Cited by in F6Publishing: 50] [Article Influence: 7.6] [Reference Citation Analysis]
31 [DOI: 10.1101/758441] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
32 Hide T, Komohara Y, Miyasato Y, Nakamura H, Makino K, Takeya M, Kuratsu JI, Mukasa A, Yano S. Oligodendrocyte Progenitor Cells and Macrophages/Microglia Produce Glioma Stem Cell Niches at the Tumor Border. EBioMedicine 2018;30:94-104. [PMID: 29559295 DOI: 10.1016/j.ebiom.2018.02.024] [Cited by in Crossref: 29] [Cited by in F6Publishing: 31] [Article Influence: 7.3] [Reference Citation Analysis]
33 Wesseling P, van den Bent M, Perry A. Oligodendroglioma: pathology, molecular mechanisms and markers. Acta Neuropathol 2015;129:809-27. [PMID: 25943885 DOI: 10.1007/s00401-015-1424-1] [Cited by in Crossref: 97] [Cited by in F6Publishing: 77] [Article Influence: 13.9] [Reference Citation Analysis]
34 Hamilton G, Rath B, Burghuber O. Chitinase-3-like-1/YKL-40 as marker of circulating tumor cells. Transl Lung Cancer Res 2015;4:287-91. [PMID: 26207216 DOI: 10.3978/j.issn.2218-6751.2015.04.04] [Cited by in F6Publishing: 10] [Reference Citation Analysis]
35 Shalaby T, Grotzer MA. Tumor-Associated CSF MicroRNAs for the Prediction and Evaluation of CNS Malignancies. Int J Mol Sci 2015;16:29103-19. [PMID: 26690130 DOI: 10.3390/ijms161226150] [Cited by in Crossref: 22] [Cited by in F6Publishing: 18] [Article Influence: 3.1] [Reference Citation Analysis]
36 Vera S, Sinning M, Vergara M, Lemus D, Rosas C. Cerebrospinal fluid VEGF levels and angiogenic capacity as potential prognostic markers in patients with gliomas: a pilot study. J Neurooncol 2019;145:233-9. [PMID: 31624989 DOI: 10.1007/s11060-019-03314-9] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
37 Verduin M, Compter I, Steijvers D, Postma AA, Eekers DBP, Anten MM, Ackermans L, Ter Laan M, Leijenaar RTH, van de Weijer T, Tjan-Heijnen VCG, Hoeben A, Vooijs M. Noninvasive Glioblastoma Testing: Multimodal Approach to Monitoring and Predicting Treatment Response. Dis Markers 2018;2018:2908609. [PMID: 29581794 DOI: 10.1155/2018/2908609] [Cited by in Crossref: 10] [Cited by in F6Publishing: 8] [Article Influence: 2.5] [Reference Citation Analysis]
38 Dietz MS, Beach CZ, Barajas R, Parappilly MS, Sengupta SK, Baird LC, Ciporen JN, Han SJ, Loret de Mola R, Cho YJ, Nazemi KJ, McClelland S 3rd, Wong MH, Jaboin JJ. Measure Twice: Promise of Liquid Biopsy in Pediatric High-Grade Gliomas. Adv Radiat Oncol 2020;5:152-62. [PMID: 32280814 DOI: 10.1016/j.adro.2019.12.008] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
39 Wurdinger T, Deumelandt K, van der Vliet HJ, Wesseling P, de Gruijl TD. Mechanisms of intimate and long-distance cross-talk between glioma and myeloid cells: how to break a vicious cycle. Biochim Biophys Acta 2014;1846:560-75. [PMID: 25453365 DOI: 10.1016/j.bbcan.2014.10.003] [Cited by in Crossref: 9] [Cited by in F6Publishing: 27] [Article Influence: 1.1] [Reference Citation Analysis]
40 Garden GA, Campbell BM. Glial biomarkers in human central nervous system disease. Glia 2016;64:1755-71. [PMID: 27228454 DOI: 10.1002/glia.22998] [Cited by in Crossref: 27] [Cited by in F6Publishing: 24] [Article Influence: 4.5] [Reference Citation Analysis]
41 Vaitkiene P, Urbanaviciute R, Grigas P, Steponaitis G, Tamasauskas A, Skiriutė D. Identification of Astrocytoma Blood Serum Protein Profile. Cells 2019;9:E16. [PMID: 31861636 DOI: 10.3390/cells9010016] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
42 Liang Z, Yang Y, Jia F, Sai K, Ullah S, Fidelis C, Lin Z, Li F. Intrathecal Delivery of Folate Conjugated near-Infrared Quantum Dots for Targeted in Vivo Imaging of Gliomas in Mice Brains. ACS Appl Bio Mater 2019;2:1432-9. [DOI: 10.1021/acsabm.8b00629] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 1.3] [Reference Citation Analysis]
43 Silantyev AS, Falzone L, Libra M, Gurina OI, Kardashova KS, Nikolouzakis TK, Nosyrev AE, Sutton CW, Mitsias PD, Tsatsakis A. Current and Future Trends on Diagnosis and Prognosis of Glioblastoma: From Molecular Biology to Proteomics. Cells 2019;8:E863. [PMID: 31405017 DOI: 10.3390/cells8080863] [Cited by in Crossref: 62] [Cited by in F6Publishing: 57] [Article Influence: 20.7] [Reference Citation Analysis]
44 Pierscianek D, Ahmadipour Y, Oppong MD, Rauschenbach L, Kebir S, Glas M, Sure U, Jabbarli R. Blood-Based Biomarkers in High Grade Gliomas: a Systematic Review. Mol Neurobiol 2019;56:6071-9. [PMID: 30719642 DOI: 10.1007/s12035-019-1509-2] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 2.3] [Reference Citation Analysis]
45 Chen L, Qin D, Guo X, Wang Q, Li J. Putting Proteomics Into Immunotherapy for Glioblastoma. Front Immunol 2021;12:593255. [PMID: 33708196 DOI: 10.3389/fimmu.2021.593255] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
46 Matias D, Balça-Silva J, da Graça GC, Wanjiru CM, Macharia LW, Nascimento CP, Roque NR, Coelho-Aguiar JM, Pereira CM, Dos Santos MF, Pessoa LS, Lima FRS, Schanaider A, Ferrer VP, Moura-Neto V; Tania Cristina Leite de Sampaio e Spohr. Microglia/Astrocytes-Glioblastoma Crosstalk: Crucial Molecular Mechanisms and Microenvironmental Factors. Front Cell Neurosci 2018;12:235. [PMID: 30123112 DOI: 10.3389/fncel.2018.00235] [Cited by in Crossref: 64] [Cited by in F6Publishing: 63] [Article Influence: 16.0] [Reference Citation Analysis]
47 He J, Jiang Y, Liu L, Zuo Z, Zeng C. Circulating MicroRNAs as Promising Diagnostic Biomarkers for Patients With Glioma: A Meta-Analysis. Front Neurol 2020;11:610163. [PMID: 33597912 DOI: 10.3389/fneur.2020.610163] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]